Search results for “Programmed death” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,626 patents, we discovered top 223 key players by total patent application. Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Bristol Myers Squibb Co. are dominant in this area. They take 26.88% of the total patent filing.
New York, United States
Patent: 163
New Jersey, United States
Patent: 147
New York, United States
Patent: 127
Hessen, Germany
Patent: 81
New Jersey, United States
Patent: 60
Noord-Brabant, Netherlands
Patent: 51
New York, United States
Patent: 44
New Jersey, United States
Patent: 39
California, United States
Patent: 38
Osaka-fu, Japan
Patent: 37
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 10 start-ups by total patent application. Capella Bioscience Ltd., SparX Therapeutics, Inc., OriCell Therapeutics Co.,Ltd. are active in this area.
STARTUP
United Kingdom
Patent: 6
STARTUP
SparX Therapeutics, Inc.
Illinois, United States
Patent: 4
STARTUP
China
Patent: 2
STARTUP
Shanghai Shi, China
Patent: 2
STARTUP
Jiangsu Sheng, China
Patent: 2
Illinois, United States
Patent: 1
STARTUP
Minnesota, United States
Patent: 1
STARTUP
Niedersachsen, Germany
Patent: 1
STARTUP
Zhejiang Sheng, China
Patent: 1
STARTUP
Guangdong Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 963 patents applied in the last 5 years. We discover 239 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Merck Sharp & Dohme LLC take 22.53% of patent filing during this period.
New York, United States
Patent: 95
New Jersey, United States
Patent: 83
New Jersey, United States
Patent: 39
New York, United States
Patent: 36
Hessen, Germany
Patent: 33
Massachusetts, United States
Patent: 25
United States
Patent: 24
New Jersey, United States
Patent: 20
California, United States
Patent: 18
Basel-Stadt, Switzerland
Patent: 16
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 963 patents in last 5 years, we discover 176 new entrants. Bolt Biotherapeutics, Inc., Mayo Foundation for Medical Education & Research, Memorial Sloan-Kettering Cancer Center are the most active new entrants in this area.
California, United States
Patent: 18
Minnesota, United States
Patent: 15
New York, United States
Patent: 10
Louisiana, United States
Patent: 10
California, United States
Patent: 10
Shanghai Shi, China
Patent: 9
Shanghai Shi, China
Patent: 9
undefined undefined
Patent: 8
Pennsylvania, United States
Patent: 8
California, United States
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 243 patents, we discovered top 53 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, Emory University are dominant in this area. They take 33.74% of the total patent filing.
United States
Patent: 45
Massachusetts, United States
Patent: 19
Georgia, United States
Patent: 10
Zhejiang Sheng, China
Patent: 8
Mie-ken, Japan
Patent: 5
Henan Sheng, China
Patent: 5
Jiangsu Sheng, China
Patent: 5
Guangdong Sheng, China
Patent: 4
North Carolina, United States
Patent: 4
Jiangsu Sheng, China
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: